Clinical Trial Update: HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for GTB-3650 Trike in high-risk myeloid malignancies, including acute myeloid leukemia and myelodysplastic syndromes, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloid Malignancies

Drugs mentioned

• GTB-3650 Trike (GTB-3650 Trike)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Myeloid Malignancy, Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING